Paying bribes can add as much as 20% to the costs of typical Chinese medications, according to Yu Mingde, chief of the China Pharmaceutical Enterprises Association. He estimates that legitimate sales and marketing expenses, plus illicit disbursement like bribery, accounts for 30% to 40% of a drug’s costs. Yu urged that solid market systems be established and stronger punishments be given to those who violate the law.

Related Summaries